The bacterial genome can reveal a lot about its actual behaviour in your product: whether it has the potential to produce toxic products, survive treatments with antibiotics or produce antimicrobial compounds. Before subjecting your probiotic strains to expensive and lengthy experimentation on health benefit substantiating properties, an in silico genome assessment can provide you with the most important first insight: is the strain safe for application?
NIZO offers a fast and automated genome assessment service, specifically designed to provide you with a clear overview of the genomic potential of your strains, in the areas of:
By selecting this service, you will obtain:
Through this service, you will be able to make an informed selection on which strains are most suitable to follow up on, in more extensive and in-depth characterization studies.
As an add-on to this automated service, NIZO can support you further with a full in silico characterization of your (foreseen) probiotic strains, for instance:
© NIZO 2021 | Sitemap - Privacy Statement - Cookie Statement - Terms & Conditions
Website by: Online Marketing Agency